Nils Wilking
Karolinska Institutet(SE)
Publications by Year
Research Areas
Economic and Financial Impacts of Cancer, Health Systems, Economic Evaluations, Quality of Life, Estrogen and related hormone effects, Breast Cancer Treatment Studies, Pharmaceutical Economics and Policy
Most-Cited Works
- → ADJUVANT TAMOXIFEN IN EARLY BREAST CANCER: OCCURRENCE OF NEW PRIMARY CANCERS(1989)930 cited
- → Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial(2000)342 cited
- → The cost of cancer in Europe 2018(2020)310 cited
- → Topoisomerase IIα Gene Amplification Predicts Favorable Treatment Response to Tailored and Dose-Escalated Anthracycline-Based Adjuvant Chemotherapy in HER-2/neu–Amplified Breast Cancer: Scandinavian Breast Group Trial 9401(2006)255 cited
- → Correlation of Vascular Endothelial Growth Factor Content With Recurrences, Survival, and First Relapse Site in Primary Node-Positive Breast Carcinoma After Adjuvant Treatment(2000)254 cited
- → Health related quality of life in different states of breast cancer(2007)229 cited